Condition
Coronary Arterial Disease (CAD) clinical trials and research
As of November 12, 2026, Find a Trial lists 47 Coronary Arterial Disease (CAD) clinical trials that are recruiting, at sites in 31 countries (most in China (11), Spain (7), United States (7)). By phase: Phase 4 (8), Phase 2 (2). The most active sponsors are University of Florida (3), University of Sao Paulo General Hospital (2), Tampere Heart Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 47Clinical trials
- 31Countries
Newest Coronary Arterial Disease (CAD) clinical trials
All recruiting trials (47)
-
Red grape juice and metabolism in men with coronary disease
Researchers will test whether daily red grape juice changes the blood metabolite profile in men with chronic coronary artery disease.
-
Edoxaban vs. Apixaban in AF with CAD: Net Benefit
This trial tests whether edoxaban-based therapy provides a similar or better overall benefit than apixaban-based therapy for stroke prevention and major bleeding in adults with atrial fibrillation and coronary artery disease.
-
Revascularization of Calcified Coronary Arteries
This study tests whether measuring blood flow and pressure before and after ballooning or stenting of calcified coronary arteries can help predict how well the procedure will work for adults with heart disease.
-
OPN Balloon Use for Recanalization of Calcified Coronary Lesions
This registry tests how the SIS-OPN balloon is used in real-world patients with calcified coronary disease who have undergone PCI in North America.
-
Pulse IVL to open calcified coronary vessels in CAD
A small, early feasibility study tests the Pulse Intravascular Lithotripsy system in adults with coronary artery disease to see if it can safely open calcified arteries and improve vessel compliance.
-
Crystalline sirolimus-coated balloon for treating coronary artery disease
This tests whether a crystalline sirolimus-coated balloon is safe and effective for adults having percutaneous coronary intervention for coronary artery blockages or in-stent restenosis.
-
Predicting sudden cardiac arrest risk in people with coronary artery disease
This project will try to see if combining genetics, ECGs, blood biomarkers, imaging, and psychosocial information can predict which people with coronary artery disease are most likely to have sudden cardiac arrest.
-
Using the Supira percutaneous ventricular assist device during and after high-risk PCI
This study will try the Supira percutaneous ventricular assist device to give extra heart support during and after high-risk PCI for patients with heart failure and reduced ejection fraction.
-
Combining a drug-coated balloon and a drug-eluting stent for people with diabetes and new coronary artery blockages
This trial tests whether using a drug-coated balloon together with a drug-eluting stent works better than using either device alone for adults with diabetes who have new (de novo) coronary artery lesions.
-
Cangrelor dose adjustment using platelet testing for patients awaiting coronary procedures
This trial tests whether adjusting the cangrelor infusion based on platelet-function testing keeps platelet reactivity in the target range for adults with coronary artery disease awaiting coronary procedures.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
-
No-touch ascending aorta approach during minimally invasive coronary bypass
This tests whether a 'no-touch' way of handling the ascending aorta during minimally invasive coronary bypass keeps bypass grafts open as well as conventional off-pump bypass for people who need coronary artery bypass surgery.
-
Sivelestat sodium treatment after off-pump coronary artery bypass grafting (OPCABG)
This trial will test whether giving sivelestat sodium after off-pump coronary bypass surgery helps protect the heart and reduce inflammation in adults having OPCABG.
-
Comparing super high-pressure balloon and intravascular lithotripsy to prepare severely calcified coronary arteries
This trial tests whether a super high-pressure balloon works as well as intravascular lithotripsy to prepare severely calcified coronary lesions in adults getting drug-eluting stents.
-
Shockwave therapy to improve leg wound healing after no-touch saphenous vein harvesting for coronary bypass
This trial will test whether applying shockwave therapy to the leg incision right after no-touch saphenous vein harvesting can reduce wound healing problems in adults having coronary artery bypass grafting.
-
Adding Compound Danshen and Qishen Yiqi pills for older adults with ongoing angina after standard heart treatment
This study will test whether adding two traditional Chinese medicine pills (Compound Danshen Dripping Pill and Qishen Yiqi Dripping Pill) helps people aged 75–89 who still have angina after standard medical treatment.
-
Switching from clopidogrel to low-dose prasugrel after PCI in people at high bleeding and ischemic risk
We will test whether switching adults who had PCI and are at both high bleeding and ischemic risk from standard-dose clopidogrel to low-dose prasugrel lowers platelet reactivity compared with staying on clopidogrel.
-
Plasma NT‑proBNP and the extent of coronary artery disease
This project tests whether a blood NT‑proBNP level can indicate how much coronary artery disease someone referred for elective coronary angiography has.
-
Contactless vibrometer pulse‑wave test for heart and artery health
This pilot will try a contactless laser‑Doppler vibrometry and microwave radar device (Cardio P4) in people aged 58–72 to see if it can detect arterial stiffness and signs of coronary artery disease, aortic stenosis, or heart failure.
-
Using Medipixel XA technology for heart artery procedures
This study is testing a new technology called Medipixel XA to see if it can make heart artery procedures safer and more effective for people with coronary artery disease.
-
Heart outcomes after drug-eluting balloon treatment for coronary blockages
This project will see if adults who had coronary angioplasty with drug-eluting balloons have different rates of major heart problems and survival.
-
Evaluating heart function and blood flow in patients with coronary artery disease
This study is trying to see how well the heart works and how blood flows in people with coronary artery disease by using special imaging and stress tests.
-
AGENT drug-coated balloon versus standard PCI for de novo coronary lesions
This trial tests whether the AGENT drug-coated balloon is a safe and effective alternative to drug-eluting stents or standard balloon angioplasty for adults with new (de novo) coronary artery lesions undergoing PCI.
-
Combining CT Angiography and Perfusion for Heart Disease Assessment
This study is testing if using a combination of advanced heart imaging techniques can help doctors better understand and treat people with coronary artery disease.
-
Using cold therapy inside coronary arteries to stabilize high‑risk plaque in people with angina or recent heart attack
This trial will try a device that delivers cold inside a coronary artery to see if it reduces dangerous plaque in people with symptomatic coronary artery disease (stable angina or recent acute coronary syndrome).
-
Comparing two techniques for treating complex coronary bifurcation lesions
This study is testing two different ways to treat complex heart artery blockages to see which one helps patients feel better and have fewer heart problems after the procedure.
-
Orticumab to reduce coronary artery inflammation after a heart attack
This tests whether orticumab can reduce coronary artery inflammation over six months in people who had a heart attack and show high inflammation on coronary CT angiography.
-
Optimal stent deployment strategy for thinner-strut bioresorbable scaffolds guided by intracoronary imaging
This study tests whether using a thinner-strut bioresorbable scaffold with OCT/IVUS imaging guidance improves outcomes in adults with stable CAD undergoing PCI.
-
Reduced-dose prasugrel alone after PCI in acute and chronic coronary syndrome
This test tries whether taking a low 5 mg daily dose of prasugrel alone after a successful PCI can prevent clots while lowering bleeding risk in people with acute or chronic coronary syndromes.
-
Drug-coated balloons for different types of coronary artery disease
This registry will try drug-coated balloons as an alternative or addition to stents in people with coronary artery disease to see if they work well and last over time.
-
AI detection of hidden coronary occlusions and timing of treatment for heart attacks
This project tests whether an AI reading of 12‑lead ECGs can find hidden coronary occlusions in adults with suspected non‑ST‑elevation ACS and whether the time to PCI after that detection relates to troponin peak levels.
-
Comparing plasma proteins and metabolites in coronary artery disease patients
This study is trying to find new blood markers in people with different types of coronary artery disease to see if they can help predict heart problems and lead to better treatments.
-
Nationwide cohort of elderly patients with coronary heart disease in China
This study is trying to gather health information from older patients with coronary heart disease in China to help improve their treatment and predict their health risks better.
-
Impact of Cardiac Rehabilitation on DNA Damage and Inflammation in Heart Disease Patients
This study is testing if cardiac rehabilitation can reduce DNA damage and inflammation in people with coronary artery disease to help improve their heart health.
-
Comparing two types of drug-coated balloons for heart artery treatment
This study tests whether sirolimus-coated balloons work better and are safer than paclitaxel-coated balloons for treating heart artery blockages in patients undergoing angioplasty.
-
Beta-blockers to improve coronary blood flow and resistance in people with angina and no blocked coronary arteries
This trial will see if a beta-blocker (metoprolol) helps people with angina but no obstructive coronary arteries by improving coronary blood flow and lowering small-vessel resistance compared with a placebo.
-
Preventive stenting for vulnerable coronary plaques in ACS patients
This trial will test whether adding a preventive percutaneous intervention to optimal medical therapy helps people with acute coronary syndrome who have non-flow-limiting vulnerable coronary plaques.
-
Sirolimus-coated versus paclitaxel-coated balloon treatment for new coronary bifurcation blockages
This trial tests whether a sirolimus-coated balloon works better and is as safe as a paclitaxel-coated balloon for adults aged 18–80 with new (de novo) coronary bifurcation blockages.
-
Identifying risk factors for sudden cardiac arrest in coronary artery disease patients
This study is trying to find out what clinical and genetic factors might increase the risk of sudden cardiac arrest in people with coronary artery disease.
-
Using a chest tube to reduce heart rhythm issues after heart surgery
This study is testing if using a special chest tube after heart surgery can help reduce the chances of patients developing heart rhythm problems like atrial fibrillation.
-
Evaluating plaque progression in coronary artery disease using advanced imaging techniques
This study is testing how advanced imaging can help us understand the growth of plaque in the arteries of people with coronary artery disease over five years and how different factors and treatments affect their heart health.
-
Integrated care for older patients with atrial fibrillation
This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.
-
Comparing orbital atherectomy and intravascular lithotripsy for calcified coronary nodules
This pilot trial will see if orbital atherectomy or intravascular lithotripsy better prepares OCT-identified calcified coronary nodules for stent placement in adults with coronary artery disease.
-
Evaluating ShockPulse-10 for treating coronary artery calcification
This study is testing a new treatment called ShockPulse-10 to see if it can safely help people with serious coronary artery calcification who are getting stents.
-
Inspiratory muscle training for heart disease patients after angioplasty
This study tests whether a special breathing exercise program can help heart disease patients feel better and exercise more after having angioplasty.
-
Using Shockwave technology to treat calcified coronary artery disease
This study is testing a new shockwave treatment to see if it can safely help people with hard, calcified arteries feel better before they get stents.
-
Comparing antiplatelet therapies after heart procedures
This study is testing whether a new way of managing blood-thinning medications after heart procedures can help people with heart issues avoid problems while also reducing the risk of bleeding.
Related topics
Quick answers
How many Coronary Arterial Disease (CAD) clinical trials are recruiting right now?
47, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 31 countries. The most sites are in China (11 trials), Spain (7 trials), United States (7 trials), Italy (4 trials), South Korea (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 8, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.